The prognostic analysis further revealed that these expression patterns translated to clinical outcomes, with high ZIP4 and ZIP7 expression generally associated with poorer outcomes, whereas ZIP6 showed a positive association with prognosis in breast cancer. This evidence concerns the gene SLC39A6 and breast cancer.